These findings align with prior studies identifying KMT2D, TP53, CYLD, NFKBIA, and PIK3CA—and their respective roles in the p53, NF-κB, and PI3K pathways—as frequently altered in NPC, further supporting their critical roles as potential driver mutations [20,21]. The gene discussed is CYLD; the disease is nasopharyngeal carcinoma.